Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31013172

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Jun 1
First author
Davis LE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Davis LE
      type
      Author
    2. name
      Bolejack V
      type
      Author
    3. name
      Ryan CW
      type
      Author
    4. name
      Ganjoo KN
      type
      Author
    5. name
      Loggers ET
      type
      Author
    6. name
      Chawla S
      type
      Author
    7. name
      Agulnik M
      type
      Author
    8. name
      Livingston MB
      type
      Author
    9. name
      Reed D
      type
      Author
    10. name
      Keedy V
      type
      Author
    11. name
      Rushing D
      type
      Author
    12. name
      Okuno S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Davis LE
      type
      Author
    2. name
      Bolejack V
      type
      Author
    3. name
      Ryan CW
      type
      Author
    4. name
      Ganjoo KN
      type
      Author
    5. name
      Loggers ET
      type
      Author
    6. name
      Chawla S
      type
      Author
    7. name
      Agulnik M
      type
      Author
    8. name
      Livingston MB
      type
      Author
    9. name
      Reed D
      type
      Author
    10. name
      Keedy V
      type
      Author
    11. name
      Rushing D
      type
      Author
    12. name
      Okuno S
      type
      Author
    bibliography ids
    1. nci-bib-6e390b665b4d70fcabbfd5be
    book metadata
    content sha256
    09d2548293567880ee52d9cc176984a15970d806296ddda31a70392aace8d0fc
    document type
    citation
    dois
    1. 10.1200/JCO.18.02374
    electronic publication date
    display
    2019 Apr 23
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31013172
    immutable id
    pubmed:31013172@09d2548293567880ee52d9cc176984a15970d806296ddda31a70392aace8d0fc
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    16
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1424-1431
    volume
    37
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31013172
      provenance
      batch id
      e808962322f3afebc564
      provider
      NCBI PubMed ESummary
      record sha256
      c6e55782083e48b54d8778ffcea54031677e62e1e88820711d9fe80379d230ff
      response sha256
      3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
      retrieved at
      2026-09-09T23:47:41.002093+00:00
      publication date
      display
      2019 Jun 1
      precision
      day
      year
      2019
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31013172/
      title
      Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

      Preserved source evidence · Not medical advice